In general, for patients with ccRCC, we demonstrated similar mutation prevalence across quartiles of FOLH1 expression, with the exception of mutations in KDM5C, which were less commonly observed in tumors with higher FOLH1 expression. The gene discussed is KDM5C; the disease is nonpapillary renal cell carcinoma.